inflammation
Scientists have discovered that regulatory T cells, a type of white blood cell, constantly move throughout the body looking for and repairing damaged tissue. It was believed that regulatory T cells exist as multiple populations restricted to specific parts of the body. Now, researchers have found that they roam around the body as a single large population of cells and target areas of inflammation, which destroys nerves and leads to a loss of movement. Researchers at the University of Cambridge say this discovery of “new rules of the immune system” could improve the treatment of inflammatory di...
Euronews (English)
Over the years, researchers have learned that chronic inflammation may be to blame in an increasing number of illnesses that were not originally thought to be inflammatory. Of course, inflammation has been implicated in many forms of arthritis and autoimmune diseases. Thus, targeting inflammation is becoming an even bigger and bigger market opportunity for biotech companies. According to one estimate, the global anti-inflammatory therapeutics market was worth $99.6 billion in 2021 and is expected to reach $127.5 billion by 2030 – a compound annual growth rate of 4.5% between 2022 and 2030. Tar...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら